SCHEMBL475645

SCHEMBL475645

Cc1cc(Cc2cc(C)cc(C(C)(C)C)c2C=CC(=O)O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 2/20 0.63
HIF1A Q16665 4/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
CYP2C9 P11712 3/20 0.61
CYP2C19 P33261 3/20 0.61
CYP2D6 P10635 2/20 0.56
HSD17B10 Q99714 1/20 0.56
ALDH1A1 P00352 3/20 0.44
CA2 P00918 1/20 0.44
POLB P06746 1/20 0.44
TYR P14679 1/20 0.44
GABBR2 O75899 2/20 0.40
GABBR1 Q9UBS5 2/20 0.40
TNFRSF1A P19438 1/20 0.36
GLRA3 O75311 1/20 0.36
GLRB P48167 1/20 0.36
TP53 P04637 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
AKR1B10 O60218 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4413753 1.00 HSPA5 (0.63) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL7189547 0.93 HSPA5 (0.50) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL19732823 0.89 HSPA5 (0.49) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL3359609 0.87 HSPA5 (0.53) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL275967 0.87 SMN1; SMN2 (0.49) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL3353518 0.87 HSPA5 (0.44) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL4220907 0.83 SMN1; SMN2 (0.49) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL15464152 0.83 HSPA5 (0.55) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
SCHEMBL2698991 0.83 CYP2C9 (0.61) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19
Acrylic Acid SCHEMBL9820642 0.82 HSPA5 (0.73) HSPA5HIF1ASMN1; SMN2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4455241-A1 CHEMICAL-RESISTANT REACTIVE PRESSURE SENSITIVE ADHESIVE TAPE TESA SE (DE) 2024-10-30 EP claimed
EP-3331945-B1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-10-07 EP claimed
US-20180223075-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-08-09 US claimed
EP-1896542-B1 PLASTICIZED FUNCTIONALIZED PROPYLENE COPOLYMER ADHESIVE COMPOSITION EXXONMOBIL CHEMICAL PATENTS INC (US) 2018-06-20 EP claimed
EP-3331945-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC Global Technologies B.V. (NL) 2018-06-13 EP claimed
EP-3169423-B1 PROCESS FOR PREPARING POLYALKENAMERS FOR PACKAGING APPLICATIONS EVONIK DEGUSSA GMBH (DE) 2018-01-03 EP claimed
EP-1896537-B1 FUNCTIONALIZED PROPYLENE COPOLYMER ADHESIDE COMPOSITION EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-10-11 EP claimed
WO-2017021124-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-02-09 WO claimed
EP-2213368-B1 Packaging body SUMITOMO CHEMICAL CO (JP) 2013-05-01 EP claimed
EP-2172512-B1 Granular stabilizer for polymer and production process thereof SUMITOMO CHEMICAL CO (JP) 2013-04-03 EP claimed
EP-0505162-B1 Polyamide blow molded product TORAY INDUSTRIES (JP) 1996-01-24 EP claimed
EP-0530984-B1 Stabilized polyolefin composition SUMITOMO CHEMICAL CO (JP) 1995-11-15 EP claimed
EP-0416321-B1 Crystalline polyolefin composition CHISSO CORP (JP) 1994-11-09 EP claimed
EP-0335815-B1 Gel prevention in polymers GOODYEAR TIRE & RUBBER (US) 1994-03-09 EP claimed
EP-0209679-B1 FLAME RETARDANT POLYOLEFIN RESIN COMPOSITION Chisso Corporation (JP) 1991-10-23 EP claimed
EP-0128739-B1 METHOD OF MANUFACTURING A HOMOPOLYMER OR COPOLYMER OF TRIOXANE POLYPLASTICS CO. LTD. (JP) 1989-07-26 EP claimed
EP-0129369-B1 METHOD OF MANUFACTURING A COPOLYMER OF TRIOXANE POLYPLASTICS CO. LTD. (JP) 1988-09-14 EP claimed
EP-0079806-B1 STABILIZED POLYMERS AND THEIR PRODUCTION AND STABILIZERS THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-05-07 EP claimed
US-4579935-A STEREO-HINDERING PHENOLS TO MONOMER MIXTURE; LEWIS ACID CATALYSTS OR COMPLEXES POLYPLASTICS CO., LTD. (JP) 1986-04-01 US claimed
US-4547565-A ADDING A STERICALLY HINDERED PHENOL TO MONOMERS, CATION-ACTIVE CATALYST POLYPLASTICS COMPANY, LTD. (JP) 1985-10-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180223075-A1 PIPE FOR THE TRANSPORT OF WATER HAVING IMPROVED RESISTANCE TO CHLORINATED DISINFECTANTS AQP1, POLI, AQP3 HSPA5 1820/4885HIF1A 2211/4885SMN1; SMN2 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.